Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 81
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03595644 | Maintenance Targeted Therapy With or Without Stereotactic Body Radiation Therapy for Stage IV Non-small Cell Lung Cancer | ||
| NCT06713421 | Effect of Premedication With Pronase on Mucosal Cleanliness During EGD | ||
| NCT06854107 | Intratumoral and Peritumoral Habitat Radiomics of MRI Predict Pathologic Complete Response to Neoadjuvant Chemoimmunotherapy in Oral Squamous Cell Carcinoma | ||
| NCT06810492 | The Efficacy and Safety of CDK4/6 Inhibitors in Combination with Endocrine Therapy in the Neoadjuvant Treatment | ||
| NCT05717738 | Combined TACE, TKI/Anti-VEGF and ICIs as Conversion Therapy for Advanced Hepatocellular Carcinoma | ||
| NCT07209787 | SIS-Reinforced vs. Conventional Anastomosis for Mid-to-Low Rectal Cancer: A Multicenter RCT on Anastomotic Leak | ||
| NCT01863303 | Epidemiological Study of Colorectal Cancer in WuHan | ||
| NCT04735861 | Sintilimab Plus Bevacizumab in Recurrent/Persistent Ovarian Clear Cell Carcinoma | ||
| NCT06037733 | Primary Tumor Radiotherapy Omitting CTV for Patients With Advanced NSCLC Responded to Immunotherapy and Chemotherapy | ||
| NCT06020430 | Omitting CTV for Locally Advanced NSCLC Responded to Immunotherapy and Chemotherapy | ||
| NCT03230708 | Clinical Study of Autologous Erythrocytes Derived MPs Packaging MTX Peritoneal Perfusion to Treat Malignant Ascites | ||
| NCT06440018 | INSPIRE: a Multi-Cancer Early Detection Study | ||
| NCT05520801 | Primary Hepatobiliary Cancer Cohort of Central China | ||
| NCT04074538 | the National Colorectal Cancer Cohort (NCRCC) Study: National Colorectal Cancer Research Consortium | ||
| NCT06714084 | CNCMT：a Multi-center, Prospective, Single-arm Study | ||
| NCT03025399 | Clinical Study of Tang Wang Prescription Intervene Diabetic Non-proliferative Retinopathy | ||
| NCT05372198 | Surufatinib With or Wothout Immunotherapy for Advanced Colorectal Cancer in Later Line | ||
| NCT05992870 | Neoadjuvant Radiotherapy and Immediate Implant-Based Breast Reconstruction | ||
| NCT06136026 | Integrated Chinese and Western Medicine Specialized Disease Cohort for Colorectal Cancer | ||
| NCT04125849 | Mediastinoscopy-assisted Transhiatal Esophagectomy Versus Thoraco-laparoscopic Esophagectomy for Esophageal Cancer | ||
| NCT02605265 | Trial of Capecitabine With or Without Irinotecan Driven by UGT1A1 | ||
| NCT03801200 | Apatinib Combined With Radiotherapy in Patient With BM From Drive Gene Negative NSCLC | ||
| NCT07264998 | Observational Study of Gut Microbiota in Abemaciclib-Treated Patients With and Without Diarrhea | ||
| NCT07264985 | Gut Microbiota and Diarrhea in Breast Cancer Patients Receiving Pyrotinib | ||
| NCT07002346 | INVIGORATE: A Study of QL1706 and Bevacizumab in Advanced First-Line Ovarian Clear Cell Carcinoma | ||
| NCT05583409 | SBRT Combined With Osimertinib Compared With Osimertinib for Stage IV NSCLC | ||
| NCT03210064 | Clinical Study of Apatinib and 5-Fu Combination Regimen to Treat Advanced Colorectal Cancer Patients | ||
| NCT05661357 | Disitamab Vedotin Combined With Fruquintinib for mCRC With HER2 Expression | ||
| NCT05342792 | Metronomic Capecitabine With or Without PD-1 Antibody as Adjuvant Therapy in High-risk Nasopharyngeal Carcinoma | ||
| NCT07188857 | Study on the Relationship Between Opioid Drugs and the Therapeutic Efficacy of Immunotherapy | ||
| NCT03663153 | SEMA4C as a Relapse Biomarker in Breast Cancer | ||
| NCT03154983 | The Clinical Research of Mesylate Apatinib Combined With Docetaxel and S-1 as the First-line Treatment of Metastatic Gastric Cancer | ||
| NCT07405346 | A Trial for Advanced Leiomyosarcoma With Human Organoid-guided Personalized Efficacy | ||
| NCT06468566 | Identification of Benign and Malignant Breast Nodules Using Ultrasound-modulated Optical Tomography: A Multicenter Study | ||
| NCT02974933 | Apatinib Mesylate Combined With Pemetrexed in the Treatment of Pretreated Advanced Non-squamous Non-small Cell Lung Cancer | ||
| NCT05021328 | Toripalimab Combined With Anlotinib and SBRT in Patients With Untreated Brain Metastases of Driven Gene-negative NSCLC | ||
| NCT05565014 | Safety and Efficacy Study of Virus Activated Killer Immune Cells (VAK) for Malignant Pleural and Peritoneal Effusion | ||
| NCT05219851 | The Risk Factors for Acute Radiation Pneumonitis in Patients With Prior Receipt of Immune Checkpoint Inhibitors | ||
| NCT07130643 | Efficacy and Safety of CDK4/6 Inhibitors Combined With Endocrine Therapy in HR+/HER2- Neoadjuvant Therapy for Early Breast Cancer | ||
| NCT02288195 | CONVERT: Neoadjuvant Chemotherapy Alone Versus Preoperative Chemoradiation for Locally Advanced Rectal Cancer Patients | ||
| NCT05476965 | Selected De-escalation Radiotherapy for Postoperative Head and Neck Squamous Cell Carcinoma | ||
| NCT06818955 | Orlistat Overcoming Third-generation EGFR-TKI Resistance | ||
| NCT06050109 | The Benefits of Continued Use of Ovarian Function Suppression After 5 Years | ||
| NCT05621473 | Comparing the Safety and Effectiveness of Tunnel PICC Guided by EDUG and Conventional PICC | ||
| NCT06329206 | A Phase Ia/Ib Study of GH2616 Tablet in Subjects With Advanced Solid Tumors | ||
| NCT07263347 | DIEP Flap Breast Reconstruction: Perioperative Biomarkers and Outcomes | ||
| NCT07250204 | A Study on Combined Low-pass Whole-genome and Methylome Testing of Bloody Nipple Discharge Specimens for Benign-Malignant Differentiation. | ||
| NCT05044871 | Biomarker-driven Targeted Therapy in Patients With Recurrent Platinum-resistant Epithelial Ovarian Cancer | ||
| NCT02562599 | Chemoradiotherapy for Patients With Locally Advanced Nasopharyngeal Carcinoma Using Raltitrexed-Cisplatin | ||
| NCT02623595 | A Study of SBRT in Combination With rhGM-CSF for Stage IV NSCLC Patients Who Failed in Second-line Chemotherapy |
